Trials / Completed
CompletedNCT00707447
Evaluation of a Primary Type 2 Diabetes Prevention Programme
Evaluation of a Teaching and Treatment Programme for Primary Prevention of Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 182 (actual)
- Sponsor
- Forschungsinstitut der Diabetes Akademie Mergentheim · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A type 2 diabetes prevention programme, named PREDIAS was developed. It consists of 12 lessons delivered as group sessions. Die efficacy of PREDIAS was studied in a randomized controlled study with 12 month follow up. Control group received written information about diabetes risk. Primary outcome variable was weight reduction at 12 months follow up. Secondary variables were impact of the intervention on glycemic parameters, lipids, eating and exercise behavior and other metabolic risk factors
Detailed description
The PREDIAS programme was developed based on the interventions used in the Diabetes Prevention Study (DPS, Finland) and the Diabetes Prevention Programme (DPP; USA). The main purpose of PREDIAS was to develop a prevention programme delivered as a group programme to improve cost-benefit ration of diabetes prevention programmes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PREDIAS | Group programme aiming at modification of lifestyle: lifestyle changes, 12 lesson a 90 minutes, delivered in a group setting, consists of analysis of barriers against lifestyle changes, behavior analysis of eating and exercise behavior, modification of unhealthy lifestyle and relapse prevention |
| BEHAVIORAL | Control | Written Information about diabetes risks. Brochure about the value of a healthy lifestyle, calorie table, suggestions for healthy food and daily exercise |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2005-12-01
- Completion
- 2008-05-01
- First posted
- 2008-06-30
- Last updated
- 2014-08-25
- Results posted
- 2014-08-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00707447. Inclusion in this directory is not an endorsement.